Christopher D. Koprowski

Author

Christiana Care Health System ORCID

Also Known As

C Koprowski, C. Koprowski, C.D. Koprowski, Christopher D. Koprowski, Christopher Koprowski

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Christiana Care Health System Texas Oncology The University of Texas MD Anderson Cancer Center Emory University Washington University in St. Louis

About

Christopher D. Koprowski is an author at Christiana Care Health System specializing in medicine, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	2.2K
2	Engineering	2	2	151
3	Health Sciences	1	1	10
4	Natural Sciences	1	1	131
5	Biomedical Engineering	1	1	131

Christopher D. Koprowski

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, The Lancet Oncology Consolidation CarboplatinOncologyRadiation TherapyRtog 0617Stage Iiia	2015	2K
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Journal of Clinical Oncology	2019	540
Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer Benjamin Movsas, Chen Hu, Jeffrey A. Sloan, JAMA Oncology	2015	177
Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinium in Patients With Brain Metastases Patrice Carde, Robert Timmerman, Minesh P. Mehta, Journal of Clinical Oncology	2001	132
Reduce in Variation and Improve Efficiency of Target Volume Delineation by a Computer-Assisted System Using a Deformable Image Registration Approach K. S. Clifford Chao, Shreerang Bhide, Hansen Chen, International Journal of Radiation OncologyBiologyPhysics EngineeringVolume ParameterizationBiomedical EngineeringImage AnalysisImage Registration	2007	131
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 Jian‐Yue Jin, Chen Hu, Ying Xiao, Cancers	2021	110
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617 Bree R. Eaton, Stephanie L. Pugh, Jeffrey D. Bradley, JNCI Journal of the National Cancer Institute	2016	99
Female Urethral Reconstruction Izak Faiena, Christopher D. Koprowski, Hari Tunuguntla The Journal of Urology	2015	63
Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617) Jian‐Yue Jin, Chang‐Ping Hu, Yufen Xiao, International Journal of Radiation OncologyBiologyPhysics Cooperative Group TrialRadiation MedicineRadiation TherapyMedicineImmunology	2017	56
External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma Christopher D. Koprowski, K.G. Berkenstock, A.M. Borofski, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineIodine ImplantRadiation TherapyProstate Carcinoma	1991	40

Page 1